Search

Your search keyword '"Millefiorini, E"' showing total 250 results

Search Constraints

Start Over You searched for: Author "Millefiorini, E" Remove constraint Author: "Millefiorini, E"
250 results on '"Millefiorini, E"'

Search Results

1. Invasive treatment of acute stroke

4. Post-marketing of disease modifying drugs in multiple sclerosis: An exploratory analysis of gender effect in interferon beta treatment

5. Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological Society

10. Effectiveness of Natalizumab on Multiple Sclerosis patients: the Italian registry experience

16. Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial

17. Safety, tolerability and effectiveness of dimethyl fumarate in multiple sclerosis: an independent, multicenter, real-world study

19. Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society

20. Predictors of definite Multiple Sclerosis in patients with pediatric onset first demyelinating clinical attack

21. Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment

22. Real-life impact of early interferon beta therapy in relapsing multiple sclerosis

23. post marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in intereron beta treatment

24. rel-life impact of early interferon beta therapy in relapsing multiple sclerosis

26. Heterogeneous impact of an early IFN beta treatment on disability progression in relapsing remitting MS subgroups with differnt baseline clinical profiles

28. Short-term brain atrophy changes in relapsing-remitting multiple sclerosis

32. Supportive strategies to improve adherence to IFN β-1b in multiple sclerosis - Results of the βPlus observational cohort study

33. Clinical features of Sjogren's syndrome in patients with multiple sclerosis

35. Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis

36. Gender ratio of multiple sclerosis in Italy: geographical distribution and trend over 60 years

38. Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

39. The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL

43. Health-related quality of life in multiple sclerosis: Effects of natalizumab

45. The incidence and significance of anti-natalizumab antibodies. Results from the AFFIRM and SENTINEL

46. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

47. Multiple sclerosis in twins from continental Italy and Sardinia: A nationwide study

48. Detection of human herpesviruses and polyomaviruses DNA in a group of patients with relapsing-remitting multiple sclerosis

Catalog

Books, media, physical & digital resources